Sensex Climbs Around 291 Points, Nifty Closes Above 24,100 as IT and Pharma Shares Lift Market

Indian equities staged a recovery on June 22, 2026, shaking off the previous session's slide as the benchmark Sensex rose about 291 to 292 points and the Nifty closed above the 24,100 mark. Strength in information technology and pharmaceutical shares anchored the rebound, helping the market regain footing after a five-day rally had earlier been snapped.

What drove the rebound

Defensive and export-oriented sectors did much of the heavy lifting. IT majors and pharmaceutical names, including Tech Mahindra and Sun Pharma, featured prominently in market coverage as gainers, while broader indices also ended in positive territory, signalling that the buying was not confined to a handful of heavyweights.

The advance was notable because it came against a backdrop of continued caution over Middle East tensions and the associated risk to energy prices. That domestic buyers stepped in despite the external uncertainty suggested resilience in local sentiment, at least for the session.

The global backdrop

Markets have been navigating a delicate mix of geopolitical risk and commodity-price sensitivity. Heightened tensions in the Middle East keep crude oil firmly in focus for India, a major energy importer, since sustained price spikes can pressure inflation, the current account and corporate margins.

Even so, the rotation into IT and pharma reflects a familiar defensive playbook. Both sectors draw significant overseas revenue and are seen as relatively insulated from domestic demand swings, making them natural havens when investors want exposure to equities without taking on full cyclical risk.

What investors are watching next

Analysts will be watching whether the Nifty can hold above key support zones and build on the rebound, or whether the bounce proves a single-session reprieve. The durability of the move will likely hinge on a cluster of well-known variables.

• Whether the Nifty can sustain levels above the 24,100 support zone.
• The direction of Brent crude prices amid Middle East tensions.
• Foreign institutional investor flows into and out of Indian equities.
• Corporate earnings expectations for the upcoming results season.
• The relative strength of defensive IT and pharma versus cyclical sectors.

“Domestic buying and sector rotation can offset global uncertainty for a day, but extending the rebound will depend on crude, flows and earnings.”

— Market strategist

For now, the session offered a measure of relief and a reminder that India's domestic investor base can provide a cushion when global headlines turn jittery. Whether that cushion holds will become clearer as crude prices, foreign flows and earnings expectations come into sharper view in the days ahead.

The NE Times View

A one-day rebound led by IT and pharma is reassuring but tells us little; markets have shrugged off West Asian risk before, then reacted sharply when oil moved. The steadier signal is the defensive tilt toward export-facing sectors. Investors should read this as resilience under tension, not all-clear, and keep one eye on crude and the rupee rather than the daily points tally.

This article is original commentary and analysis by The NE Times. Background facts were referenced from The Economic Times and Business Standard.